| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0002 |